U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Policies and Procedures

Listed below are the policies used by the WTC Health Program:

Adding to the List of WTC-Related Health Conditions

Aerodigestive Disorders


  • Rare Cancers [PDF, 1 page, 247 KB]

    Issue Date: May 5, 2014

    This document defines and lists WTC-related health conditions in the category of "Rare Cancers."

  • Malignant Neuroendocrine Neoplasms [PDF, 4 pages, 352 KB]

    Issue Date: October 4, 2013

    This document provides information regarding the certification of malignant neuroendocrine neoplasm as a “rare cancer,” regardless of the anatomic site where identified. Each determination of any malignant neoplasm must be considered for certification as a WTC-related health condition under the minimum latency requirements for solid cancers, and the exposure requirements specified by the WTC Health Program in the WTC-3 Certification Request form.

  • Minimum Latency & Types or Categories of Cancer [PDF, 12 pages, 624 KB]

    Revised: January 6, 2015

    As new scientific information becomes available to the WTC Program Administrator on minimum latencies for the types or categories of cancers on the List of WTC-Related Health Conditions found at 42 C.F.R. § 88.1, minimum latencies may be modified. The Administrator's May 1, 2013, revision to the White Paper on Minimum Latency & Types or Categories of Cancer changes minimum latencies for mesothelioma and the category of lymphoproliferative and hematopoietic cancers.

    Previous Versions:

  • Myeloid Malignancies [PDF, 9 pages, 381 KB]

    Issue Date: February 1, 2014

    Beginning on February 1, 2014, the World Trade Center (WTC) Health Program will consider blood or bone marrow disorders of the myeloid line to be slow-growing blood cancers. Accordingly, they will be considered WTC-related health conditions, making them available for WTC Health Program medical treatment services for eligible members. These cancers had been considered non-malignant by the Administrator because they were referred to as “pre-leukemic” hematopoietic disorders in the medical literature. Recent scientific advances, however, characterize these “pre-leukemic” myeloid neoplasms as slow-growing blood cancers, and authoritative scientific sources now consider them to be malignant myeloid neoplasms.

  • Policy and Procedures for Cancer Screening [PDF, 4 pages, 348 KB]

    Issue Date: April 2, 2014

    This document describes the purpose and procedure for cancer screening

Medically Associated Health Conditions

Privacy Practices

Recoupment and Coordination of Benefits

Transportation Services